• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ADHD:US

18.2400 USD 0.2400 1.33%

As of 17:20:00 ET on 07/25/2014.

Snapshot for Alcobra Ltd (ADHD)

Open: 17.9600 Day's Range: 17.7400 - 18.4400 Volume: 80,553
Previous Close: 18.0000 52wk Range: 9.5700 - 26.9600 1-Yr Rtn: +78.82%

Stock Chart for ADHD

No chart data available.
  • ADHD:US 18.2400
  • 1D
  • 1M
  • 1Y
18.0000
Interactive ADHD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ADHD

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.4500
Est. EPS (USD) (12/2014) -2.1370
Est. PEG Ratio -
Market Cap (M USD) 248.73
Shares Outstanding (M) 13.64
30 Day Average Volume 164,559
Price/Book (mrq) 5.8862
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ADHD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ADHD

Alcobra Ltd. operates as a biopharmaceutical company. The Company develops a patented, non-stimulant pharmaceutical drug designed to treat Attention Deficit Hyperactivity Disorder. Alcobra provides its products to the medical and pharmaceutical industries.

Yaron DanielyPresident/CEOTomer BerkovitzChief Financial Officer
Jonathan RubinChief Medical OfficerHanna RonSenior VP:CMC
More Company Profile & Key Executives for ADHD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil